
Andrew Jallouk
Assistant Professor · Vanderbilt University Medical Center
Credentials: · · · · · · · ·
History


2006–2010
Research
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
Journal of the National Comprehensive Cancer Network · 2024 · 118 citations
Cytolytic nanoparticles attenuate HIV-1 infectivity
Antiviral Therapy · 2013 · 75 citations
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
Blood Advances · 2023 · 44 citations

12 papers

11 papers
- BS
9 papers
- JJ
9 papers
- RJ
9 papers

8 papers

8 papers · 3 as a fellow

8 papers
Clinical trials
- 2024–2032
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Site PI · Recruiting · Phase 2
Allogene Therapeutics


